Organogenesis Holdings Inc(NASDAQ:ORGO) 
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic allograft wound cove...
Website: http://organogenesis.com
Founded: 1985
Full Time Employees: 835
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.00
H 4.04
L 3.67
C 3.87
V 1,820,512
10EMA 3.87
20EMA 3.87
60EMA 3.87
120EMA 3.87
250EMA 3.87